Jasti, IN
Karteek Jasti, Tenali IN
Patent application number | Description | Published |
---|---|---|
20090307651 | Computing Platform for Structured Data Processing - This patent discloses a computing platform to process structured data. The computer platform may include a component layer having a workflow engine to execute a workflow definition. The workflow engine may receive feed data from a user system. The workflow engine may send a business logic application and feed data to a distributed computation environment to batch process the feed data through the business logic application as part of executing the workflow definition. | 12-10-2009 |
Purna Chandra Jasti, Madhapur IN
Patent application number | Description | Published |
---|---|---|
20140082433 | SCSI Reservation Status Information on a SAN Disk - A method is disclosed for retrieving the reservation status information of a storage area network (SAN) device, a host transmits a persistent reservation in command with service action setting of ‘read reservation’ to a first LUN, wherein the host is connected to a port of the data storage server to which the LUN belongs. The host receives a message from the LUN. The host determines that the message is a success. The host sends to the LUN a persistent reservation in command with service action setting of ‘read keys’, responsive to a success message. The host determines that the LUN responds with a zero data length. The host determines the LUN is reserved with type 2 reservation, responsive to a determination that the LUN responds with a non-zero data length. | 03-20-2014 |
Purnachandra R. Jasti, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20140304434 | CONTINUOUSLY TRANSFERRING DATA USING A USB MASS STORAGE DEVICE - A method for continuous data transfer when a USB mass storage device is disconnected and reconnected is provided. The method may include monitoring state information from one or more mass storage devices, using a software driver to detect a change in state of the mass storage device on the computer. Active I/O transfers using the USB mass storage device are paused when the software driver detects that the USB mass storage device is detached from the computer. A configurable timer is started. The software drive may detect the attaching of a USB device. If, prior to the expiration of the timer, the software driver verifies that the USB mass storage device is the same that was previously attached to the computer, active I/O transfers are continued. | 10-09-2014 |
20140304435 | CONTINUOUSLY TRANSFERRING DATA USING A USB MASS STORAGE DEVICE - A method for continuous data transfer when a USB mass storage device is disconnected and reconnected is provided. The method may include monitoring state information from one or more mass storage devices, using a software driver to detect a change in state of the mass storage device on the computer. Active I/O transfers using the USB mass storage device are paused when the software driver detects that the USB mass storage device is detached from the computer. A configurable timer is started. The software drive may detect the attaching of a USB device. If, prior to the expiration of the timer, the software driver verifies that the USB mass storage device is the same that was previously attached to the computer, active I/O transfers are continued. | 10-09-2014 |
Srikanth Jasti, Bangalore, Karnataka IN
Patent application number | Description | Published |
---|---|---|
20160085766 | COMPACTING DATA BASED ON DATA CONTENT - An example method for data compaction is disclosed in accordance with an aspect of the present disclosure. The method may include receiving, at a computing device, data files associated with an account. The method may also include determining, by the computing device, whether the account has expired. The method may also include, in response to determining that the account has expired, compacting, by the computing device, the data files associated with the account based on the content of the data files. | 03-24-2016 |
Vankaleswaru Jasti, Andra Pradesh IN
Patent application number | Description | Published |
---|---|---|
20100041673 | 5-(HETEROCYCLYL)ALKYL-N-(ARYLSULFONYL)INDOLE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS - Compounds including 5-(Heterocyclyl)alkyl-N-(arylsulfonyl)indole, their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them and a process for the preparation of these compounds, their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. These compounds are useful in the treatment of various disorders that are related to 5-HT6 receptor functions. Specifically, the compounds of this invention are also useful in the treatment of various CNS disorders, hematological disorders, eating disorders, diseases associated with pain, respiratory diseases, genito-urological disorders, cardiovascular diseases and cancer. | 02-18-2010 |
Vankateswarlu Jasti, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20100190996 | Process for the Preparation of Losartan - The invention relates to an improved process for the preparation of Losartan. The process comprising reacting 2-n-butyl-4-chloro-5-formyl imidazole with 2-(4-bromomethyl) benzonitrile in the presence of a phase transfer catalyst and an alkali, and reducing the resulting cyano aldehyde to produce a cyano alcohol which is further reacted with sodium azide in N-methyl pyrrolidinone and a salt to produce Losartan. | 07-29-2010 |
Venkateswarlu Jasti, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20090131507 | N-arylsulfonyl-3-aminoalkoxyindoles - N-arylsulfonyl-3-aminoalkoxyindoles indole compounds, radioisotopes, stereoisomers, geometric forms, N-oxides, polymorphs and pharmaceutically acceptable salts. | 05-21-2009 |
20100087484 | AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS - The present invention relates to novel aminoalkoxy arylsulfonamide compounds of the formula (I), their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. These compounds are useful in the treatment of various disorders that are related to 5-HT | 04-08-2010 |
20100168168 | Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands - The present invention provides aminoaryl sulphonamide derivatives of formula (I), useful in the treatment of a CNS disorder related to or affected by the 5-HT | 07-01-2010 |
20100216861 | AMINO ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS - The present invention relates to novel amino arylsulfonamide compounds of the formula (I), their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them: The present invention also relates to a process for the preparation of above said novel compounds, their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The compounds of the invention are useful in the treatment of various disorders that are related to 5-HT | 08-26-2010 |
20110281849 | Aryl Indolyl Sulfonamide Compounds and Their Use as 5-HT6 Ligands - The present invention relates to novel aryl indolyl sulfonamide compounds of the formula (I), their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates described herein and pharmaceutically acceptable compositions containing them. | 11-17-2011 |
20120129816 | ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS - The present invention relates to novel aryl sulfonamide amine compounds of the formula (I), their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates described herein and pharmaceutically acceptable compositions containing them. | 05-24-2012 |
20120277216 | 1,2-DIHYDRO-2-OXOQUINOLINE COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS - The present invention relates to novel 1,2-dihydro-2-oxoquinoline compounds of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. | 11-01-2012 |
20120315657 | FUNCTIONAL ASSAY FOR 5-HT2A, HISTAMINE H1 OR ADRENERGIC ALPHA 1B RECEPTORS - The present invention provides novel functional assay for 5-HT | 12-13-2012 |
20120322808 | Alpha 4 Beta 2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS - The present invention relates to novel α | 12-20-2012 |
20130005709 | SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS - The present invention relates to novel sulfone compounds as 5-HT | 01-03-2013 |
20140135304 | NOVEL COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS - The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. | 05-15-2014 |
20140148440 | HETEROCYCLYL COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS - The present invention relates to heterocyclyl compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to Histamine H | 05-29-2014 |
20140187581 | HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS - The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. | 07-03-2014 |
20150218129 | ACRYLAMIDE COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS - The present invention relates to novel acrylamide compounds of formula (I), and their pharmaceutically acceptable salts and process of their preparation. (The chemical formula should be inserted here.) The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine H | 08-06-2015 |
20150283125 | HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS - The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. | 10-08-2015 |
Venkateswarlu Jasti, Andra Pradesh IN
Patent application number | Description | Published |
---|---|---|
20090203907 | Novel intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole - An improved process for the preparation of aripiprazole (1) which comprises (i) reacting 6-hydroxy-l-indanone (11) with 1,4-dihalobutane (12) in the presence of a base and a solvent at a temperature in the range of 90 to 110 deg C. to form the novel intermediate 6-(4-halo butoxy)-indan-1-one (3), (ii) reacting the novel intermediate with 1-(2,3-clichlorophenyl)-piperazine (9) to get another novel intermediate 6-[4-[4-(2,3-dichlorophenyl)-l-piperazinyl]butoxy]-indan-l-one (2) and (iii) reacting the resulting novel compound with sodium azide. The invention also relates to the novel intermediates of the formulae (2) & (3) and processes for their preparation. The invention also includes intermediate compounds useful for the preparation of aripiprazole. | 08-13-2009 |
20100041669 | 4-(HETEROCYCLYL)ALKYL-N-(ARYLSULFONYL)INDOLE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS - Compounds including 4-(Heterocyclyl)alkyl-N-(arylsulfonyl)indole compounds of the formula (I), their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them as well as a process for the preparation of these compounds, their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. These compounds are useful in the treatment of various disorders that are related to 5-HT | 02-18-2010 |
Venkateswarlu Jasti, Andhra Pradesh IN
Patent application number | Description | Published |
---|---|---|
20100204501 | PROCESS FOR THE PREPARATION OF MALATHION AND ITS INTERMEDIATE - The present invention relates to the improved process for the preparation of highly pure form of S-[1,2-(dicarbethoxy)-ethyl]O,O-dimethyl phosphorodithioate having formula (I). The compound of formula (I) has adopted name “Malathion”. The present invention also relates to the novel process of preparing intermediate O,O-dimethyldithiophosphoric acid of formula (II), which is useful in the preparation of Malathion. The Malathion prepared by the process of this invention is highly storage stable and toxic impurities are much lower than any other commercial preparation available for the pharmaceutical purpose. | 08-12-2010 |
20130072518 | BICYCLIC COMPOUNDS AS alpha4 beta2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS - The present invention relates to novel bicyclic compounds of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. These compounds are useful in the treatment and prevention of various disorders that are related to α | 03-21-2013 |